Condamine J-L, Marcucci L, Hanouz N
Service d'Orthopédie, Etablissements Hospitaliers du Bessin, 13, rue Nesmond, BP 18127, 14401 Bayeux Cedex.
Rev Chir Orthop Reparatrice Appar Mot. 2007 Feb;93(1):46-55. doi: 10.1016/s0035-1040(07)90203-2.
The aim of this study was to present our experience with hemiarthroplasty of the base of the first metacarpal for the treatment of degenerative disease of the trapeziometacarpal joint. We have used this resurfacing implant since 1995 as part of our therapeutic armamentarium together with trapeziectomy, arthrodesis and total arthroplasty.
The chromium-cobalt implant is inserted into the base of the first metacarpal. Three implant sizes are available. The present series included 106 implants in 87 patients, predominantly female. Mean patient age was 59.6 years. Three quarters of the patients had isolated joint degeneration. The preoperative complaint was pain (scored 3 on a 4-point scale) for 92% of patients. Joint motion was generally not impaired. Grip force was limited with less than 50% force for first finger-thumb opposition in three quarters of the patients. The anterior Gedda-Möberg approach was used in all cases. The joint was immobilized for two to three weeks postoperatively.
There were seven complications among the 106 cases: reflex dystrophy (n=4), global pain (n=2) and rupture of the long extensors (n=1). Sixty nine patients (83 implants) were reviewed at more than one year follow-up. Mean follow-up was 53 months (range 23 - 128 months). Activities were resumed at two months for 88% of implants with no problem for grip force for one-third and normal activity for 66%. Patient assessment was: outcome good and very good for 94%, pain free for 52%, and moderate pain without impaired activity for 43% (Kapandji opposition score was normal in 90%). Grip force was decreased in 25%. Radiographically, all implants were stable. Joint centering was improved (from 25% to 60% at last follow-up). There was no correlation between radiographic centering and clinical outcome.
This hemiarthroplasty has provided satisfactory results in terms of pain relief, joint motion, and function. There has not been any long-term radiographic problem. If revision is needed for failure, the procedure is simple and trapeziectomy, total arthroplasty or arthrodesis can be performed. The hemi-implant can be inserted after total arthroplasty. Compared with other techniques, this implant avoids the problem of silicone tolerance with the Swanson implant and has provided results superior to those of arthrodesis and trapiezectomy but slightly less satisfactory than with total arthroplasty. The indication for use of this resurfacing implant is osteoarthritis of a centered trapeziometacarpal in the young subject. The implant is contraindicated for advanced-stage disease, stiff joint with retraction of the first commissure and hyperextension of the metacarpophalangeal joint.
本研究旨在介绍我们采用第一掌骨基底半关节成形术治疗大多角掌骨关节退行性疾病的经验。自1995年以来,我们一直将这种表面置换植入物作为治疗手段之一,与大多角骨切除术、关节融合术和全关节成形术一起使用。
铬钴合金植入物被植入第一掌骨基底。有三种植入物尺寸可供选择。本系列包括87例患者的106枚植入物,患者以女性为主。患者平均年龄为59.6岁。四分之三的患者存在孤立性关节退变。92%的患者术前主诉为疼痛(在4分制中评分为3分)。关节活动通常未受损害。四分之三的患者在拇指与示指对捏时握力受限,小于正常力的50%。所有病例均采用前侧Gedda-Möberg入路。术后关节固定两至三周。
106例中有7例出现并发症:反射性交感神经营养不良(4例)、全身性疼痛(2例)和指长伸肌断裂(1例)。69例患者(83枚植入物)在随访一年以上时接受了复查。平均随访时间为53个月(范围23 - 128个月)。88%的植入物在两个月时恢复活动,三分之一的患者握力无问题,66%的患者可正常活动。患者评估结果为:94%的患者结果良好或非常好,52%的患者无痛,43%的患者有中度疼痛但活动未受影响(90%的患者Kapandji对捏评分正常)。25%的患者握力下降。影像学检查显示,所有植入物均稳定。关节对中度得到改善(最后一次随访时从25%提高到60%)。影像学对中度与临床结果之间无相关性。
这种半关节成形术在缓解疼痛、关节活动和功能方面取得了令人满意的结果。尚未出现任何长期影像学问题。如果因失败需要翻修,手术操作简单,可以进行大多角骨切除术、全关节成形术或关节融合术。全关节成形术后可插入半植入物。与其他技术相比,这种植入物避免了Swanson植入物的硅胶耐受性问题,其结果优于关节融合术和大多角骨切除术,但略逊于全关节成形术。这种表面置换植入物的使用指征是年轻患者中大多角掌骨关节居中的骨关节炎。晚期疾病、第一关节间隙挛缩且关节僵硬以及掌指关节过伸的患者禁用该植入物。